勃林格殷格翰的思力华在国内买的到吗？

(Respimat) Inhalation of tiotropium bromide through Respimat combined with a spacer can better improve the lung function indicators and blood gas indicators of patients with chronic obstructive pulmonary disease, and obtain better clinical effect analysis, suggesting that the combined use of spacers in the treatment of COPD can achieve better clinical effects and provide certain guidance for clinical treatment. So, is such effective Boehringer Ingelheim’s Spiriva available in China?

Boehringer Ingelheim's Slivar has been on the market in China for more than ten years, and the drug is currently included in the national medical insurance catalog and is a Class B drug in the medical insurance. Although patients cannot be reimbursed in full when purchasing drugs, it can also reduce a certain financial burden for patients. Patients in need can purchase the needed Siliva at major hospitals in the country.

In order to reduce out-of-pocket expenses as much as possible, patients can also purchase drugs overseas to obtain more cost-effective Silivar. It is understood that a box of Siliva sold overseas costs 170 US dollars. Patients in need can not only go abroad to purchase the required drugs in person, but also contact some professional and formal domestic overseas medical service organizations (such as Medical Companion Travel) to obtain their specific drug purchase channels.

Boehringer Ingelheim is currently the largest and most successful privately held pharmaceutical group in the world. It was founded by Albert Boehringer in 1885 and is located in Ingelheim, not far from Frankfurt, Germany. Boehringer Ingelheim has gradually gained an important position in the market. At first, the company only produced chemical products such as lactic acid and tartaric acid. Today, it has launched many well-known drugs. It has made huge investments and created many excellent products in the fields of respiratory, central nervous system, gastrointestinal tract, cardiovascular and cerebrovascular diseases. It has now successfully ranked among the top 20 pharmaceutical companies in the world. Among them, the drug developed by Boehringer Ingelheim has been launched at home and abroad. Patients in need can selectively purchase drugs based on their own needs.

Recommended hot articles: /newsDetail/92350.html